Skip to content
Disclosery

EXANE DERIVATIVES: SLB position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SLB, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 18,872 SLB shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 18,872 shares
    Change vs previous 13F -17,866 shares

    0.39% of the 13F portfolio, value $674,714.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 36,738 shares
    Change vs previous 13F +19,403 shares

    0.43% of the 13F portfolio, value $1,517,532.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 17,335 shares
    Change vs previous 13F -38,527 shares

    0.13% of the 13F portfolio, value $519,157.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 55,862 shares
    Change vs previous 13F +85 shares

    0.41% of the 13F portfolio, value $1,655,668.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 55,777 shares
    Change vs previous 13F +6,660 shares

    0.4% of the 13F portfolio, value $1,707,281.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 49,117 shares
    Change vs previous 13F +11,008 shares

    0.4% of the 13F portfolio, value $1,335,410.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 38,109 shares
    Change vs previous 13F +10,166 shares

    0.25% of the 13F portfolio, value $831,867.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 27,943 shares
    Change vs previous 13F not available

    0.14% of the 13F portfolio, value $434,775.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).